Your browser doesn't support javascript.
loading
Genetic Loss of miR-205 Causes Increased Mammary Gland Development.
Cataldo, Alessandra; Cheung, Douglas G; Hagan, John P; Fassan, Matteo; Sandhu-Deol, Sukhinder; Croce, Carlo M; Di Leva, Gianpiero; Iorio, Marilena V.
Afiliação
  • Cataldo A; Research Department, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
  • Cheung DG; Comprehensive Cancer Center, Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH 43210, USA.
  • Hagan JP; Department of Neurosurgery, The University of Texas Health Science Center at Houston, Houston, TX 77054, USA.
  • Fassan M; Department of Medicine, DIMED, University of Padua, 35122 Padua, Italy.
  • Sandhu-Deol S; Veneto Institute of Oncology, IOV-IRCSS, 35128 Padua, Italy.
  • Croce CM; Comprehensive Cancer Center, Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH 43210, USA.
  • Di Leva G; Comprehensive Cancer Center, Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH 43210, USA.
  • Iorio MV; School of Pharmacy and Bioengineering, Keele University, Keele ST5 5BG, UK.
Noncoding RNA ; 10(1)2023 Dec 31.
Article em En | MEDLINE | ID: mdl-38250804
ABSTRACT
MiRNAs play crucial roles in a broad spectrum of biological processes, both physiological and pathological. Different reports implicate miR-205 in the control of breast stem cell properties. Differential miR-205 expression has been observed in different stages of mammary gland development and maturation. However, a functional role in this process has not been clearly demonstrated. We generated an miR-205 knockout in the FVB/N mouse strain, which is viable and characterized by enhanced mammary gland development. Indeed, mammary glands of miR-205-/- female mice at different ages (1.5 and 5.5 months) show increased outgrowth and branching. This evidence is consistent with our previously reported data demonstrating the direct miR-205-mediated targeting of HER3, a master regulator of mammary gland development, and the oncosuppressive activity of this microRNA in different types of breast cancer.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article